New online toolkit aims to ease financial stress for young adults with type 1 diabetes

NCT ID NCT06348160

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a toolkit of short videos and online resources designed to help young adults (ages 18-30) with type 1 diabetes handle health insurance and financial stress. Researchers will track changes in financial stress, health insurance knowledge, diabetes quality of life, and blood sugar levels over one year. The goal is to see if this toolkit can improve self-management and reduce stress, especially for those on Medicaid or from diverse backgrounds.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
iHERO Toolkit (online videos and resources)
What this could lead to
If successful, this toolkit could help young adults with type 1 diabetes better manage health insurance and financial stress, potentially improving their diabetes control and quality of life.
What could go wrong
This is a small, early-stage study (195 participants) testing a behavioral tool, not a medical treatment. The toolkit may not work for everyone, and results may not apply to all young adults with type 1 diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital Los Angeles

    Los Angeles, California, 90027, United States

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • University Hospitals

    Cleveland, Ohio, 44106, United States

  • University of Florida Diabetes Institute

    Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.